Department of Ophthalmology and Visual Sciences

August 19, 2014

Keeping an eye on blast trauma

Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

By Leigh MacMillan
August 14, 2014

VEI taking novel approach to fight blinding diseases

Personalized medicine — the effort to tailor health care to individual patients’ needs, genetic profiles and circumstances — is a well-established concept at Vanderbilt University Medical Center.

By Jessica Pasley
July 10, 2014

Meranze, Penn named to new Faculty Affairs roles

Two veteran faculty members are assuming new roles as associate deans within Vanderbilt University School of Medicine’s Office of Faculty Affairs.

By Nancy Humphrey
March 20, 2014

Virtual reality simulator hones eye surgery skills

Virtual reality environments are a common feature used in the aviation industry to train pilots, and now they’re also proving to be a very effective tool in educating the next generation of ophthalmological surgeons at Vanderbilt University Medical Center.

By Jessica Pasley
March 14, 2014

Protein boosts retinal neuron survival

An ion channel protein called TRIPV1 helps retinal neurons survive the elevated eye pressure associated with glaucoma.

By Leigh MacMillan
January 31, 2014

Vanderbilt ophthalmologist offers tips for healthy eyes in winter

By Jessica Pasley
January 30, 2014

Orthoptist association honors Vanderbilt’s Biernacki

The American Association of Certified Orthoptists (AACO) recently presented Ronald Biernacki, associate in Ophthalmology and Visual Sciences at Vanderbilt, the Lancaster Award, the highest award an orthoptist can receive.
By Jessica Pasley
October 31, 2013

Penn named to vision group’s scientific advisory panel

John Penn, Ph.D., vice chair of the Department of Ophthalmology and Visual Sciences at Vanderbilt, has been named to the Research to Prevent Blindness (RPB) Scientific Advisory Panel.
By Jessica Pasley
September 27, 2013

Metabolic profiling of vision loss

A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.
By Leigh MacMillan
September 19, 2013

Team tracking new options to treat glaucoma

Three years ago, a team of researchers led by David Calkins, Ph.D., vice chair and director of Research at the Vanderbilt Eye Institute, showed that the first sign of injury in glaucoma, the leading cause of blindness in the United States, occurs in the brain.
By Jessica Pasley
July 25, 2013

Grant to support blindess research

Research to Prevent Blindness (RPB) recently awarded a $110,000 grant to Vanderbilt’s Department of Ophthalmology and Visual Sciences in support of research into the causes, treatment and prevention of blinding diseases.
By Jessica Pasley
July 17, 2013

Vanderbilt ophthalmologist stresses summer eye safety

By Jessica Pasley
June 26, 2013

Insights on glaucoma gene mutations

Glaucoma-causing mutations in the gene for myocilin reduce secretion of the protein into the aqueous humor, suggesting a new option for treatment.
By Leigh MacMillan
1 … 6 7 8 9 10